By-health(SZ:300146)2025-03-27 09:14Group 1: Financial Performance and Budgeting - The company aims to maintain stable budget targets for 2025 compared to 2024, focusing on cautious and stable overall financial management [2] - Sales expense ratio guidance for the upcoming year is expected to be controlled effectively, supported by enhanced management capabilities [2] - In 2024, the company invested 750 million in advertising, with plans to refine advertising strategies for better consumer engagement in 2025 [3] Group 2: Product Development and Market Strategy - The company has launched proprietary probiotic strains, specifically LPB27, to enhance product differentiation and cater to niche markets [3] - Lifespace brand development is a priority, with ongoing resource investment to establish it as a preferred brand in the probiotic category [3] - Plans to expand the product matrix and create new application scenarios to strengthen product advantages in the market [4] Group 3: Sales Channels and Competition - The company will implement dealer and terminal activation plans to enhance service capabilities and market coverage in 2025 [4] - Strategies include increasing the quality of e-commerce operations while reducing ineffective business scales, focusing on sustainable growth [4] - The company acknowledges the competitive pressure from online channels and plans to diversify product offerings to meet changing consumer preferences [5] Group 4: Pricing Strategy - Price discrepancies across different sales channels are attributed to channel characteristics and promotional activities [5] - The company aims to establish a differentiated multi-product strategy across channels to address pricing inconsistencies [5]